Lv3
238 积分 2025-03-17 加入
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
2天前
已完结
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
15天前
已完结
Rational Design of the First Dual Agonist at Trace Amine-Associated Receptor 1 and 5-HT2C Receptors Based on Binding Pocket Similarity for the Treatment of Schizophrenia and Alzheimer’s Disease-Related Psychosis
25天前
已完结
Schizophrenia
25天前
已完结
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
26天前
已完结
Pimavanserin could be useful for treating psychosis in Parkinson disease
26天前
已完结
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
26天前
已完结
The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats
27天前
已完结
A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease
28天前
已完结
Treatment of Tardive Dyskinesia
28天前
已完结
皖公网安备34019202002308
